Articles by ‘Bharti Moore’

After more than 4 years of debate in the UK since the referendum and after years of negotiation with the EU about, first, a withdrawal agreement and then an agreement setting out how the future trade in some areas between the EU and the UK should work, the UK-EU Trade and Cooperation Agreement was finally signed yesterday by the EU and the UK governments.

Completing an M&A deal is a very exciting moment for all parties concerned. A great deal of hard work has been undertaken by the buyer to find the right target to purchase, analyse the benefits, synergies and cost-saving opportunities, carry out due diligence, negotiate the key documents and finally complete the deal.

As 1 January 2021 is fast approaching, we look at how this may impact on the flow of personal data between the UK and the EU, and what Banks can do to prepare.

With the post-Brexit transition period ending in 31 December 2020 and talks between the EU and UK about a Free Trade Agreement (“FTA”) continuing, businesses need to continue to prepare for the key challenges ahead.

On 9 November 2020 I had the pleasure of speaking at the 13th Annual European GRC and GDPR compliance conference hosted by Copenhagen Compliance.

UK Finance has just published its 2020 Half Year Fraud report, which revealed that in the first half of the year, a total of £207.8 million was lost to authorised push payment (APP) fraud.

The UK BioIndustry Association, BIA, has just released its investment report for the period 1 June to 31 August 2020.

With the end of the Brexit transition period fast approaching it is becoming more and more urgent for businesses in the medical sector to prepare for the transition period coming to an end. It is a sector, where many of the rules stem from EU regulation, which makes it even more important for businesses to prepare.

Since its launch in May 2020, the Future Fund has proven to be extremely popular, with applications in excess of the initially funding commitment of £250million.

In the wake of the controversy surrounding the allegations of modern slavery of a Leicester factory supplying online fashion brand Boohoo, now is not the time for Boards to take their eyes off the ball.

As the social, economic, and health impacts of COVID continue to ripple around the globe, it would seem that the UK Biotech sector is weathering the storm. But despite its robust response, there are warming signs that should not be ignored.

Despite the ongoing challenges faced by UK businesses, as lockdown measures ease and businesses start to re-open and adjust to a new way of working, directors across all sectors will be looking ahead and need to maintain a ‘hands on’ approach to considering, implementing and communicating key decisions.